May 8, 2018 / 11:18 PM / 2 years ago

Jazz Pharmaceuticals to settle U.S. probe for $57 million

BOSTON, May 8 (Reuters) - Jazz Pharmaceuticals plc on Tuesday said that it had agreed to pay $57 million to resolve a U.S. probe into its financial support of charities that offer assistance to Medicare patients seeking help to cover out-of-pocket drug costs.

The drugmaker in a filing with the U.S. Securities and Exchange Commission said that it reached an agreement in principle with the U.S. Justice Department to pay the sum as part of a civil settlement. (Reporting by Nate Raymond in Boston; Editing by Sandra Maler)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below